Katrina J. Church - Mar 15, 2024 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
SVP & Chief Compliance Officer
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Mar 15, 2024
Transactions value $
$0
Form type
4
Date filed
3/22/2024, 05:21 PM
Previous filing
Mar 18, 2024
Next filing
Apr 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Award $0 +17.5K $0.00 17.5K Mar 15, 2024 Class A Common Stock 17.5K Direct F1, F2
transaction BVS Restricted Stock Units Award $0 +26.9K $0.00 26.9K Mar 15, 2024 Class A Common Stock 26.9K Direct F1, F3
transaction BVS Stock Option (Right to Buy) Award $0 +40K $0.00 40K Mar 15, 2024 Class A Common Stock 40K $5.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2 The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date.
F3 The RSUs shall vest on June 15, 2024, subject to the Reporting Person continuing in service through the applicable vesting date.